BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32427375)

  • 21. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
    Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
    J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer.
    Yin W; He Q; Hu Z; Chen Z; Qifeng M; Zhichun S; Zhihui Q; Xiaoxia N; Li J; Gao J
    Vaccine; 2010 Jul; 28(31):4937-44. PubMed ID: 20653081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer cells synergistically defend against CD8
    Li D; Zhou X; Xu W; Chen Y; Mu C; Zhao X; Yang T; Wang G; Wei L; Ma B
    Cancer Med; 2023 Aug; 12(15):16405-16415. PubMed ID: 37501397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.
    Saif JM; Vadakekolathu J; Rane SS; McDonald D; Ahmad M; Mathieu M; Pockley AG; Durrant L; Metheringham R; Rees RC; McArdle SE
    Eur J Immunol; 2014 Apr; 44(4):994-1004. PubMed ID: 24338683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
    Seledtsov VI; Goncharov AG; Seledtsova GV
    Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L; Xie Y; Ahmed KA; Ahmed S; Sami A; Chibbar R; Xu Q; Kane SE; Hao S; Mulligan SJ; Xiang J
    Breast Cancer Res Treat; 2013 Jul; 140(2):273-84. PubMed ID: 23881522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+ T-cell activity and promotes immune escape.
    Yang J; Chen J; Liang H; Yu Y
    Cancer Sci; 2022 Sep; 113(9):3044-3054. PubMed ID: 35598173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.
    Cecil DL; Holt GE; Park KH; Gad E; Rastetter L; Childs J; Higgins D; Disis ML
    Cancer Res; 2014 May; 74(10):2710-8. PubMed ID: 24778415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles from
    Luo ZW; Xia K; Liu YW; Liu JH; Rao SS; Hu XK; Chen CY; Xu R; Wang ZX; Xie H
    Int J Nanomedicine; 2021; 16():2949-2963. PubMed ID: 33907401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node.
    Cheng L; Wang Y; Huang L
    Mol Ther; 2017 Jul; 25(7):1665-1675. PubMed ID: 28284981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling.
    Xiong HY; Ma TT; Wu BT; Lin Y; Tu ZG
    Asian Pac J Cancer Prev; 2014; 15(14):5767-72. PubMed ID: 25081699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor.
    Wang C; Huang X; Wu Y; Wang J; Li F; Guo G
    Int J Biol Sci; 2020; 16(4):633-643. PubMed ID: 32025211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy.
    Cho JA; Yeo DJ; Son HY; Kim HW; Jung DS; Ko JK; Koh JS; Kim YN; Kim CW
    Int J Cancer; 2005 Apr; 114(4):613-22. PubMed ID: 15609328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer.
    Lu J; Zhang Q; Liang CM; Xia SJ; Zhong CP; Wang DW
    Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
    Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
    Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine.
    Suckow MA; Rosen ED; Wolter WR; Sailes V; Jeffrey R; Tenniswood M
    Cancer Immunol Immunother; 2007 Aug; 56(8):1275-83. PubMed ID: 17242926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.
    Guo C; Yi H; Yu X; Zuo D; Qian J; Yang G; Foster BA; Subjeck JR; Sun X; Mikkelsen RB; Fisher PB; Wang XY
    Mol Cancer Ther; 2012 Nov; 11(11):2331-41. PubMed ID: 22896667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma.
    Zhang Y; Luo CL; He BC; Zhang JM; Cheng G; Wu XH
    Int J Oncol; 2010 Jan; 36(1):133-40. PubMed ID: 19956842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.